Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss

Journal of Vascular Surgery

Volumn 56, Issue 4, 2012, Pages 1015-1024.e1

  Barshes, Neal R ^a   Chambers, James D ^b   Cohen, Joshua ^b   Belkin, Michael ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BYPASS SURGERY; CLINICAL EVALUATION; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COMPUTER SIMULATION; CONSERVATIVE TREATMENT; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; ENDOVASCULAR SURGERY; FUNCTIONAL STATUS; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; INTERVENTION STUDY; LIMB AMPUTATION; LIMB SALVAGE; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REOPERATION; SENSITIVITY ANALYSIS; TISSUE INJURY; WOUND CARE; WOUND CLOSURE; WOUND HEALING; AMPUTATION; BLOOD VESSEL GRAFT; CONVALESCENCE; COST BENEFIT ANALYSIS; ECONOMICS; ISCHEMIA; LEG; PATHOLOGY; PROBABILITY; TREATMENT OUTCOME; VASCULARIZATION;

AMPUTATION; COHORT STUDIES; COST-BENEFIT ANALYSIS; ENDOVASCULAR PROCEDURES; HEALTH CARE COSTS; HUMANS; ISCHEMIA; LOWER EXTREMITY; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; RECOVERY OF FUNCTION; TREATMENT OUTCOME; VASCULAR GRAFTING; WOUND HEALING;

EID: 84864214506     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.02.069     Document Type: Article

References (38)

1. Orszag, P.R., Ellis, P., The challenge of rising health care costs—a view from the Congressional Budget Office. N Engl J Med 357 (2007), 1793–1795.
2. Porter, M., Olmsted Teisberg, E., Redefining health care: creating value-based competition on results. 2006, Harvard Business Press, Boston.
3. Owens, D.K., Qaseem, A., Chou, R., Shekelle, P., Clinical Guidelines Committee of the American College of Physicians. High-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med 154 (2011), 174–180.
4. Dietzek, A.M., Gupta, S.K., Kram, H.B., Wengerter, K.R., Veith, F.J., Limb loss with patent infra-inguinal bypasses. Eur J Vasc Surg 4 (1990), 413–417.
5. Barshes, N.R., Belkin, M., MOVIE Study Collaborators. A framework for the evaluation of “value” and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg 213 (2011), 552–566.e5.
6. Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease: The Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technol Assess 14 (2010), 1–210 iii-iv.
7. Taylor, S.M., Johnson, B.L., Samies, N.L., Rawlinson, R.D., Williamson, L.E., Davis, S.A., et al. Contemporary management of diabetic neuropathic foot ulceration: a study of 917 consecutively treated limbs. J Am Coll Surg 212 (2011), 532–545 discussion: 546-8.
8. Taylor, S.M., Current status of heroic limb salvage for critical limb ischemia. Am Surg 74 (2008), 275–284.
9. Bradbury, A.W., Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial in perspective. J Vasc Surg 51:5 Suppl (2010), 1S–4S.
10. Hunink, M.G., Wong, J.B., Donaldson, M.C., Meyerovitz, M.F., de Vries, J., Harrington, D.P., Revascularization for femoropopliteal disease: A decision and cost-effectiveness analysis. JAMA 274 (1995), 165–171.
11. Rutherford, R.B., Baker, J.D., Ernst, C., Johnston, K.W., Porter, J.M., Ahn, S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997), 517–538.
12. Gold, M., Siegel, J., Russell, L., Weinstein, M., Cost-effectiveness in health and medicine. 1996, Oxford University Press, New York.
13. Hunink, M., Glasziou, P., Decision making in health and medicine: integrating evidence and values. 2009, Cambridge University Press, New York.
14. Weinstein, M.C., Siegel, J.E., Gold, M.R., Kamlet, M.S., Russell, L.B., Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276 (1996), 1253–1258.
15. Riley, G.F., Administrative and claims records as sources of health care cost data. Med Care 47:Suppl 1 (2009), S51–S55.
16. NHS, National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf Accessed August 14, 2011.
17. Azoulay, A., Doris, N.M., Filion, K.B., Caron, J., Pilote, L., Eisenberg, M.J., The use of the transition cost accounting system in health services research. Cost Eff Resour Alloc, 5, 2007, 11.
18. Conte, M.S., Bandyk, D.F., Clowes, A.W., Moneta, G.L., Seely, L., Lorenz, T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006), 742–751 discussion: 751.
19. Bradbury, A.W., Adam, D.J., Bell, J., Forbes, J.F., Fowkes, F.G., Gillespie, I., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51:5 Suppl (2010), 5S–17S.
20. Lederle, F.A., Freischlag, J.A., Kyriakides, T.C., Padberg, F.T. Jr, Matsumura, J.S., Kohler, T.R., et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 302 (2009), 1535–1542.
21. Brott, T.G., Hobson, R.W. 2nd, Howard, G., Roubin, G.S., Clark, W.M., Brooks, W., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 363 (2010), 11–23.
22. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (1991), 445–453.
23. Brott, T.G., Halperin, J.L., Abbara, S., Bacharach, J.M., Barr, J.D., Bush, R.L., et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation 124 (2011), 489–532.
24. Hobson, R.W., Mackey, W.C., Ascher, E., Murad, M.H., Calligaro, K.D., Comerota, A.J., et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the society for vascular surgery. J Vasc Surg 48 (2008), 480–486.
25. Lee, W.A., Matsumura, J.S., Mitchell, R.S., Farber, M.A., Greenberg, R.K., Azizzadeh, A., et al. Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the society for vascular surgery. J Vasc Surg 53 (2011), 187–192.
26. Chaikof, E.L., Brewster, D.C., Dalman, R.L., Makaroun, M.S., Illig, K.A., Sicard, G.A., et al. The care of patients with an abdominal aortic aneurysm: the society for vascular surgery practice guidelines. J Vasc Surg 50:4 Suppl (2009), S2–S49.
27. Cronenwett, J.L., Likosky, D.S., Russell, M.T., Eldrup-Jorgensen, J., Stanley, A.C., Nolan, B.W., et al. A regional registry for quality assurance and improvement: the vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 46 (2007), 1093–1101 discussion: 1101-2.
28. Rectenwald, J.E., Upchurch, G.R. Jr, Impact of outcomes research on the management of vascular surgery patients. J Vasc Surg 45:Suppl A (2007), A131–A140.
29. Brooke, B.S., Perler, B.A., Dominici, F., Makary, M.A., Pronovost, P.J., Reduction of in-hospital mortality among California hospitals meeting leapfrog evidence-based standards for abdominal aortic aneurysm repair. J Vasc Surg 47 (2008), 1155–1156 discussion: 1163-4.
30. Clagett, G.P., Does vascular surgery cost too much?. J Vasc Surg 50 (2009), 1211–1218.
31. Braithwaite, R.S., Meltzer, D.O., King, J.T. Jr, Leslie, D., Roberts, M.S., What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?. Med Care 46 (2008), 349–356.
32. Weinstein, M.C., How much are Americans willing to pay for a quality-adjusted life year?. Med Care 46 (2008), 343–345.
33. NHS, National Institute for Health and Clinical Excellence. The guidelines manual, 2009. http://www.nice.org.uk/guidelinesmanual Accessed August 14, 2011.
34. Clemens, M.W., Attinger, C.E., Functional reconstruction of the diabetic foot. Semin Plast Surg 24 (2010), 43–56.
35. Donaldson, M.C., Mannick, J.A., Whittemore, A.D., Femoral-distal bypass with in situ greater saphenous vein: Long-term results using the mills valvulotome. Ann Surg 213 (1991), 457–464 discussion: 464-5.
36. Pomposelli, F.B., Kansal, N., Hamdan, A.D., Belfield, A., Sheahan, M., Campbell, D.R., et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg 37 (2003), 307–315.
37. Abularrage, C.J., Conrad, M.F., Hackney, L.A., Paruchuri, V., Crawford, R.S., Kwolek, C.J., et al. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg, 52, 2010 314-22.e1-4.
38. Korhonen, M., Biancari, F., Söderström, M., Arvela, E., Halmesmäki, K., Albäck, A., et al. Femoropopliteal balloon angioplasty vs. bypass surgery for CLI: a propensity score analysis. Eur J Vasc Endovasc Surg 41 (2011), 378–384.